The COVID-19 vaccine candidates developed by Moderna Inc. and BioNTech and Pfizer Inc. will require strict standards for cooling, and that may hinder how they are distributed to the hundreds of millions of Americans who expect to receive them. Shares of Modern MRNA, -3.54% were 3.6% lower in trading on …
Read More »Modern stockrally disappears as analysts weigh on what US government deal means for COVID-19 vaccine prices
The rally in shares in Moderna Inc. jumped through news late Tuesday that the U.S. government ordered 100 million doses of its COVID-19 vaccine candidate on Wednesday as analysts waited for what the order meant for prices. Modern MRNA, + 1.94% is widely regarded as a front-runner in the race …
Read More »